Q-and-A: Focus on the "underappreciated" aids growth

05/14/2007 | NYTimes.com

Becton, Dickinson & Co. makes 25 billion needles a year; its CEO says that the company is in "the middle of the food chain in terms of technical sophistication" and that much of the company's growth comes from applying technology to "underappreciated" health problems. Edward J. Ludwig, who also serves as chairman of AdvaMed, also said, "Making the right acquisitions has become more and more challenging."

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN